Amazon Biotech In Advanced Negotiations To Obtain Approvals For Sale Of Its AIDS Drug In Nigeria And Kenya
NEW YORK, NY -- (MARKET WIRE) -- December 19, 2006 -- Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D), announced today that it is in negotiations with a European company to obtain approvals for sale of its AIDS drug in Nigeria and Kenya.